According to the National Organization for Rare Disorders (NORD), over 7,000 rare diseases impact millions of patients, yet fewer than 500 have FDA-approved treatments. For patients living with rare diseases, the journey to a diagnosis is often long and difficult, with many facing misdiagnoses or remaining undiagnosed for years.

At Clinakos Inc., we’re dedicated to changing this narrative. Our platform provides unparalleled access to rare disease and oncology populations, encompassing over 1,500 diseases and connecting with 2,400+ advocacy groups, registries, and physician panels. This extensive network, combined with our Integrated Patient Data™ and Medically Smart AI™, empowers us to support more accurate and timely diagnoses.

By leveraging vast amounts of real-world data and AI-driven insights, Clinakos helps life sciences companies develop more targeted and effective treatments. Our integrated approach not only enhances diagnostic accuracy but also accelerates the journey toward better patient outcomes for those living with rare diseases.

Contact us today to explore how our solutions can revolutionize your patient outcomes and make a meaningful difference in the lives of those affected by rare diseases.
https://lnkd.in/gMznWZ3J